Title : Could anti IL12/23 therapy replace anti-TNF biologics?

Pub. Date : 2009

PMID : 19818214






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anti-TNF agents were developed approximately one decade ago by rheumatologists and today represent one of the most effective classes of drugs in severe psoriasis resistant to 2 out of 3 "classic" systemic therapies (methotrexate, cyclosporine, and PUVA). Cyclosporine tumor necrosis factor Homo sapiens